RNA Market Cap History



Below is a table of the RNA market cap history going back to 6/12/2020:

Date RNA Market Cap
6/12/2020882.10M
7/20/2020876.25M
10/20/20201.02B
2/26/2021906.92M
4/26/2021944.90M
7/21/2021893.53M
10/20/20211.02B
2/7/2022803.23M
4/21/2022848.47M
10/25/2022767.38M
2/14/20231.67B
4/24/20231.19B
7/24/2023722.44M
10/23/2023373.47M
2/15/20241.08B

Also see: RNA Shares Outstanding History
and RNA YTD Return
RNA Historical Market Cap:
+5.62% CAGR
RNA Historical Market Cap: +5.62% CAGR

Mouse over chart for data details
6/12/2020 ...2/15/2024
Avidity Biosciences is a biopharmaceutical company developing a new class of RNA therapies called Antibody Oligonucleotide Conjugates (AOCs) designed to combine the specificity of monoclonal antibodies, or mAbs, with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. Co.'s lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type 1, a rare monogenic muscle disease. Co. pipeline also includes AOC 1044, the lead of three programs for the treatment of Duchenne Muscular Dystrophy, and AOC 1020, designed to treat facioscapulohumeral muscular dystrophy. We show 15 historical shares outstanding datapoints in our RNA shares outstanding history coverage, used to compute RNA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing RNA market cap history over the course of time is important for investors interested in comparing RNA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of RNA versus a peer is one thing; comparing RNA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like RNA can fluctuate over the course of history. With this page we aim to empower investors researching RNA by allowing them to research the RNA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree RNA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Avidity Biosciences (RNA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

RNAC Market Cap History
RNAZ Market Cap History
RNXT Market Cap History
RPHM Market Cap History
RPID Market Cap History
RPRX Market Cap History
RSLS Market Cap History
RTIX Market Cap History
RTRX Market Cap History
RTTR Market Cap History
More Healthcare companies »

 

RNA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.